These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16533117)

  • 1. What works, and what remains to be done, in HIV prevention in the United States.
    Holtgrave DR; Curran JW
    Annu Rev Public Health; 2006; 27():261-75. PubMed ID: 16533117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS strategy in the United States: a closing window for success?
    Holtgrave DR; Hall HI; Wehrmeyer L; Maulsby C
    AIDS Behav; 2012 Aug; 16(6):1365-72. PubMed ID: 22610372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employing resource allocation modeling to inform HIV prevention planning for the state of Iowa.
    Holtgrave DR; Young PA; Mayer RR; Maulsby C; Kim JJ
    AIDS Educ Prev; 2013 Oct; 25(5):423-9. PubMed ID: 24059879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/AIDS prevention programs to lose federal funding.
    AIDS Policy Law; 2003 May; 18(9):5. PubMed ID: 12772650
    [No Abstract]   [Full Text] [Related]  

  • 6. With infection rates rising, will the new administration stay focused on AIDS? Activists worry that HIV prevention will be ignored.
    AIDS Alert; 2001 Mar; 16(3):29-31. PubMed ID: 15446229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the effectiveness and efficiency of HIV prevention programs.
    Holtgrave DR; Qualls NL; Curran JW; Valdiserri RO; Guinan ME; Parra WC
    Public Health Rep; 1995; 110(2):134-46. PubMed ID: 7630989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New data from the CDC confirm HIV is on the rise.
    AIDS Alert; 2004 Feb; 19(2):13, 15-7. PubMed ID: 15011624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV prevention efforts reach a crossroads as signs point to rising infections. Meanwhile, politics is deciding prevention strategy.
    AIDS Alert; 2003 Jun; 18(6):69, 71-3. PubMed ID: 12866473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis.
    Holtgrave DR
    AIDS; 2002 Nov; 16(17):2347-9. PubMed ID: 12441812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of HIV prevention programs.
    Holtgrave DR; Qualls NL; Graham JD
    Annu Rev Public Health; 1996; 17():467-88. PubMed ID: 8724236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV prevention programs proven cost-effective.
    AIDS Alert; 1998 Sep; 13(9):107-8. PubMed ID: 11365792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organizational structure and resources of CDC's HIV-AIDS prevention program.
    Noble GR; Parra WC; Holman PB
    Public Health Rep; 1991; 106(6):604-7. PubMed ID: 1659705
    [No Abstract]   [Full Text] [Related]  

  • 14. The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries.
    Stover J; Bertozzi S; Gutierrez JP; Walker N; Stanecki KA; Greener R; Gouws E; Hankins C; Garnett GP; Salomon JA; Boerma JT; De Lay P; Ghys PD
    Science; 2006 Mar; 311(5766):1474-6. PubMed ID: 16456039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC change in funding could lead to big cuts. Existing prevention at risk.
    AIDS Alert; 2011 Sep; 26(9):99-101. PubMed ID: 22003533
    [No Abstract]   [Full Text] [Related]  

  • 16. Identifying gaps in HIV prevention services.
    Torrone EA; Levandowski BA; Thomas JC; Isler MR; Leone PA
    Soc Work Public Health; 2010 May; 25(3):327-40. PubMed ID: 20446179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness analysis of a proposed national falls prevention program.
    Wu S; Keeler EB; Rubenstein LZ; Maglione MA; Shekelle PG
    Clin Geriatr Med; 2010 Nov; 26(4):751-66. PubMed ID: 20934620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic analysis of prevention: an illustration involving children's behavior problems.
    Foster EM; Jones DE
    J Ment Health Policy Econ; 2007 Dec; 10(4):165-75. PubMed ID: 18166828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.
    Pinkerton SD; Holtgrave DR; Bloom FR
    AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.